Balance Sheet: Assets
Quarterly Data
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.
Paying user area
Try for free
Regeneron Pharmaceuticals Inc. pages available for free this week:
- Income Statement
- Statement of Comprehensive Income
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Solvency Ratios
- Analysis of Geographic Areas
- Price to FCFE (P/FCFE)
- Dividend Discount Model (DDM)
- Return on Assets (ROA) since 2005
- Current Ratio since 2005
- Total Asset Turnover since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Regeneron Pharmaceuticals Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Regeneron Pharmaceuticals Inc., consolidated balance sheet: assets (quarterly data)
US$ in thousands
Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
- Cash and cash equivalents
- The cash and cash equivalents exhibited significant fluctuations over the observed periods. Beginning at approximately $2.21 billion, there was a decline around mid-2020 followed by a notable increase in late 2021 reaching around $3.4 billion. After peaking, the balance decreased substantially in mid-2023, but rebounded near the end of the series, ending with fluctuations around the $2.5 to $3.0 billion mark. Overall, the cash liquidity shows variability possibly corresponding to operational needs or investment activities.
- Marketable securities (current and noncurrent)
- The current portion of marketable securities demonstrated a rising trend from early 2020 to early 2023, increasing from about $1.8 billion to more than $8 billion at its peak, before showing some decline towards the end of the series. The noncurrent marketable securities follow a similar pattern, growing from $3.2 billion to over $10 billion by mid-2025. This indicates a strategic accumulation of liquid investments or a shift towards more secure asset holdings over time.
- Accounts receivable, net
- Accounts receivable varied considerably, with an initial increase from approximately $2.9 billion in early 2020 to a peak close to $7 billion mid-2021, followed by declines and rises within a range of approximately $5 to $6 billion across subsequent periods. This fluctuation could suggest changes in sales volumes, credit policies, or collection efficiency.
- Inventories
- Inventories showed a consistent upward trend throughout the periods analyzed, rising steadily from around $1.48 billion to over $3.25 billion by early 2025. This steady increase suggests either growth in production, stockpiling in anticipation of demand, or changes in inventory management strategy.
- Prepaid expenses and other current assets
- These assets exhibited variability with occasional spikes, notably in mid-2021 and late 2023, ranging from approximately $160 million up to nearly $680 million. This variability may reflect changes in prepayments or other short-term resource allocations.
- Current assets
- Current assets showed a strong upward momentum, growing from about $8.64 billion in early 2020 to a peak near $19.3 billion in late 2023, before stabilizing somewhat. This increase is supported by rises in cash equivalents, marketable securities, accounts receivable, and inventories, indicating expanding short-term asset capacity.
- Property, plant, and equipment, net
- Net property, plant, and equipment steadily increased over the entire period from about $2.94 billion to $5 billion, reflecting continuous investment in fixed assets and possibly expansion of operational capacity.
- Intangible assets, net
- Data for intangible assets is partially available, starting near $0.8 billion in late 2022 and rising gradually to approximately $1.38 billion by mid-2025. This upward movement suggests ongoing development or acquisition of intangible assets such as patents or licenses.
- Deferred tax assets
- Deferred tax assets showed a consistent upward trend from roughly $0.77 billion early 2020 to approximately $3.85 billion by mid-2025, indicating increasing future tax benefits recognized possibly due to operating losses or other tax-related timing differences.
- Other noncurrent assets
- Other noncurrent assets remained relatively stable initially but surged markedly starting in early 2024, rising from around $470 million to about $1.67 billion by mid-2025, signaling possible new long-term investments or asset reclassifications.
- Noncurrent assets
- Noncurrent assets increased overall from about $7.11 billion in early 2020 to approximately $22.19 billion by mid-2025, supported by growth in property, plant and equipment, intangible assets, deferred tax assets, and other noncurrent assets. This reflects a significant capital base expansion over the observed periods.
- Total assets
- Total assets expanded from roughly $15.76 billion in early 2020 to over $40.17 billion by mid-2025, demonstrating substantial overall asset growth. This growth is driven by increases in both current and noncurrent asset categories, indicating strong capital investment and asset accumulation strategies.